381 related articles for article (PubMed ID: 15684051)
21. Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism.
Marowsky A; Burgener J; Falck JR; Fritschy JM; Arand M
Neuroscience; 2009 Oct; 163(2):646-61. PubMed ID: 19540314
[TBL] [Abstract][Full Text] [Related]
22. Sex and strain-based inflammatory response to repeated tobacco smoke exposure in spontaneously hypertensive and Wistar Kyoto rats.
Shen YH; Pham AK; Davis B; Smiley-Jewell S; Wang L; Kodavanti UP; Takeuchi M; Tancredi DJ; Pinkerton KE
Inhal Toxicol; 2016 Dec; 28(14):677-685. PubMed ID: 27829308
[TBL] [Abstract][Full Text] [Related]
23. Soluble epoxide hydrolase in the generation and maintenance of high blood pressure in spontaneously hypertensive rats.
Koeners MP; Wesseling S; Ulu A; Sepúlveda RL; Morisseau C; Braam B; Hammock BD; Joles JA
Am J Physiol Endocrinol Metab; 2011 Apr; 300(4):E691-8. PubMed ID: 21266668
[TBL] [Abstract][Full Text] [Related]
24. Substituted adamantyl-urea inhibitors of the soluble epoxide hydrolase dilate mesenteric resistance vessels.
Olearczyk JJ; Field MB; Kim IH; Morisseau C; Hammock BD; Imig JD
J Pharmacol Exp Ther; 2006 Sep; 318(3):1307-14. PubMed ID: 16772540
[TBL] [Abstract][Full Text] [Related]
25. An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats.
Dorrance AM; Rupp N; Pollock DM; Newman JW; Hammock BD; Imig JD
J Cardiovasc Pharmacol; 2005 Dec; 46(6):842-8. PubMed ID: 16306811
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of Chronic Pancreatitis and Murine Pancreatic Intraepithelial Neoplasia by a Dual Inhibitor of c-RAF and Soluble Epoxide Hydrolase in LSL-KrasG¹²D/Pdx-1-Cre Mice.
Liao J; Hwang SH; Li H; Liu JY; Hammock BD; Yang GY
Anticancer Res; 2016 Jan; 36(1):27-37. PubMed ID: 26722025
[TBL] [Abstract][Full Text] [Related]
27. Attenuation of cisplatin-induced renal injury by inhibition of soluble epoxide hydrolase involves nuclear factor κB signaling.
Liu Y; Webb HK; Fukushima H; Micheli J; Markova S; Olson JL; Kroetz DL
J Pharmacol Exp Ther; 2012 Jun; 341(3):725-34. PubMed ID: 22414856
[TBL] [Abstract][Full Text] [Related]
28. Soluble epoxide hydrolase: a novel target for the treatment of hypertension.
Fang X
Recent Pat Cardiovasc Drug Discov; 2006 Jan; 1(1):67-72. PubMed ID: 18221075
[TBL] [Abstract][Full Text] [Related]
29. Soluble epoxide hydrolase inhibitors and their potential for treatment of multiple pathologic conditions.
Ingraham RH; Gless RD; Lo HY
Curr Med Chem; 2011; 18(4):587-603. PubMed ID: 21143109
[TBL] [Abstract][Full Text] [Related]
30. Small Molecule Soluble Epoxide Hydrolase Inhibitors in Multitarget and Combination Therapies for Inflammation and Cancer.
Das Mahapatra A; Choubey R; Datta B
Molecules; 2020 Nov; 25(23):. PubMed ID: 33255197
[TBL] [Abstract][Full Text] [Related]
31. Soluble epoxide hydrolase inhibitor can protect the femoral head against tobacco smoke exposure-induced osteonecrosis in spontaneously hypertensive rats.
Xu J; Qiu X; Yu G; Ly M; Yang J; Silva RM; Zhang X; Yu M; Wang Y; Hammock B; Pinkerton KE; Zhao D
Toxicology; 2022 Jan; 465():153045. PubMed ID: 34801612
[TBL] [Abstract][Full Text] [Related]
32. Anti-interleukin-17 antibodies attenuate airway inflammation in tobacco-smoke-exposed mice.
Shen N; Wang J; Zhao M; Pei F; He B
Inhal Toxicol; 2011 Mar; 23(4):212-8. PubMed ID: 21456954
[TBL] [Abstract][Full Text] [Related]
33. Soluble epoxide hydrolase in rat inflammatory cells is indistinguishable from soluble epoxide hydrolase in rat liver.
Draper AJ; Hammock BD
Toxicol Sci; 1999 Jul; 50(1):30-5. PubMed ID: 10445750
[TBL] [Abstract][Full Text] [Related]
34. Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption.
Napimoga MH; Rocha EP; Trindade-da-Silva CA; Demasi APD; Martinez EF; Macedo CG; Abdalla HB; Bettaieb A; Haj FG; Clemente-Napimoga JT; Inceoglu B; Hammock BD
J Periodontal Res; 2018 Oct; 53(5):743-749. PubMed ID: 29851077
[TBL] [Abstract][Full Text] [Related]
35. Structure-based optimization of cyclopropyl urea derivatives as potent soluble epoxide hydrolase inhibitors for potential decrease of renal injury without hypotensive action.
Takai K; Nakajima T; Takanashi Y; Sone T; Nariai T; Chiyo N; Nakatani S; Ishikawa C; Yamaguchi N; Fujita K; Yamada K
Bioorg Med Chem; 2014 Mar; 22(5):1548-57. PubMed ID: 24530032
[TBL] [Abstract][Full Text] [Related]
36. Soluble epoxide hydrolase inhibition ameliorates proteinuria-induced epithelial-mesenchymal transition by regulating the PI3K-Akt-GSK-3β signaling pathway.
Liang Y; Jing Z; Deng H; Li Z; Zhuang Z; Wang S; Wang Y
Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):70-5. PubMed ID: 25986738
[TBL] [Abstract][Full Text] [Related]
37. Epoxide hydrolase activities and epoxy fatty acids in the mosquito Culex quinquefasciatus.
Xu J; Morisseau C; Yang J; Mamatha DM; Hammock BD
Insect Biochem Mol Biol; 2015 Apr; 59():41-9. PubMed ID: 25686802
[TBL] [Abstract][Full Text] [Related]
38. Soluble epoxide hydrolase inhibition provides multi-target therapeutic effects in rats after spinal cord injury.
Chen X; Chen X; Huang X; Qin C; Fang Y; Liu Y; Zhang G; Pan D; Wang W; Xie M
Mol Neurobiol; 2016 Apr; 53(3):1565-1578. PubMed ID: 25663200
[TBL] [Abstract][Full Text] [Related]
39. Soluble Epoxide Hydrolase Pharmacological Inhibition Decreases Alveolar Bone Loss by Modulating Host Inflammatory Response, RANK-Related Signaling, Endoplasmic Reticulum Stress, and Apoptosis.
Trindade-da-Silva CA; Bettaieb A; Napimoga MH; Lee KSS; Inceoglu B; Ueira-Vieira C; Bruun D; Goswami SK; Haj FG; Hammock BD
J Pharmacol Exp Ther; 2017 Jun; 361(3):408-416. PubMed ID: 28356494
[TBL] [Abstract][Full Text] [Related]
40. Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): Resulting drug levels and modulation of oxylipin pattern.
Ostermann AI; Herbers J; Willenberg I; Chen R; Hwang SH; Greite R; Morisseau C; Gueler F; Hammock BD; Schebb NH
Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt A):131-7. PubMed ID: 26117215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]